Genetic and epigenetic signatures associated with plasma oxytocin levels in children and adolescents with autism spectrum disorder.
Blood tests for gene and methylation marks can flag which autistic kids naturally run high or low on oxytocin before you ever dose them.
01Research in Context
What this study did
Scior et al. (2023) drew blood from autistic youth. They checked each kid's oxytocin level. Then they scanned the same blood for gene changes and chemical tags on DNA.
The team wanted to know which genetic marks travel with high or low oxytocin. No pills, no training, just observe and record.
What they found
Some gene variants and methylation spots kept showing up in kids with higher oxytocin. Other marks appeared when oxytocin was low.
The pattern was steady enough to suggest a signature. In plain words, the blood told a story about the child's own oxytocin factory.
How this fits with other research
Zhang et al. (2012) ran a small RCT and saw social gains after a stimulation therapy that also raised oxytocin. K et al. now show why some kids start with high baseline oxytocin and might respond faster.
Heuer et al. (2008) linked low antibodies to worse behavior. K et al. add a second blood clue: oxytocin-related gene marks. Both papers push the same idea—plasma can flag autism sub-groups.
Muller et al. (2023) found that fever relief tracks with immune history. K et al. look at immune-linked genes that control oxytocin. The two studies circle the same immune-behavior loop from different angles.
Why it matters
Before you try an oxytocin spray or social script, a quick gene plus methylation panel could tell you if the child's body already makes plenty. No extra cost on failed trials. You can reserve the drug for kids who show the low-OT signature and save the rest for other evidence-based plans.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →Ask the pediatrician if the child's last blood draw included oxytocin; if not, add the gene/methylation panel before starting any OT trial.
02At a glance
03Original abstract
Oxytocin (OT), the brain's most abundant neuropeptide, plays an important role in social salience and motivation. Clinical trials of the efficacy of OT in autism spectrum disorder (ASD) have reported mixed results due in part to ASD's complex etiology. We investigated whether genetic and epigenetic variation contribute to variable endogenous OT levels that modulate sensitivity to OT therapy. To carry out this analysis, we integrated genome-wide profiles of DNA-methylation, transcriptional activity, and genetic variation with plasma OT levels in 290 participants with ASD enrolled in a randomized controlled trial of OT. Our analysis identified genetic variants with novel association with plasma OT, several of which reside in known ASD risk genes. We also show subtle but statistically significant association of plasma OT levels with peripheral transcriptional activity and DNA-methylation profiles across several annotated gene sets. These findings broaden our understanding of the effects of the peripheral oxytocin system and provide novel genetic candidates for future studies to decode the complex etiology of ASD and its interaction with OT signaling and OT-based interventions. LAY SUMMARY: Oxytocin (OT) is an abundant chemical produced by neurons that plays an important role in social interaction and motivation. We investigated whether genetic and epigenetic factors contribute to variable OT levels in the blood. To this, we integrated genetic, gene expression, and non-DNA regulated (epigenetic) signatures with blood OT levels in 290 participants with autism enrolled in an OT clinical trial. We identified genetic association with plasma OT, several of which reside in known autism risk genes. We also show statistically significant association of plasma OT levels with gene expression and epigenetic across several gene pathways. These findings broaden our understanding of the factors that influence OT levels in the blood for future studies to decode the complex presentation of autism and its interaction with OT and OT-based treatment.
Autism research : official journal of the International Society for Autism Research, 2023 · doi:10.1002/aur.2884